简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-12-03 11:43 Gilead and AWS Collaborate on Development and Delivery of New Medicines for Patients
2021-12-03 09:22 Vifor Pharma comments on market speculations
2021-12-01 19:00 Masimo Rad-G® Helps Clinicians Identify Pediatric Pneumonia in Large Field Trial in India
2021-12-01 18:52 ITabMed Completes Series A-round Financing after Spin-off
2021-12-01 13:57 Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea
2021-11-30 20:13 New World Group’s Humansa Announces Anchor Partnership with Key Medical Institutions in the Greater Bay Area to Reinvent Personalised and Holistic Consumer Healthcare Services
2021-11-30 15:22 Aster Guardians Global Nursing Award Worth US $250,000 Now Open for Nominations From Nurses Worldwide
2021-11-30 14:15 Vifor Pharma announces changes to the Executive Committee as CFO retires
2021-11-30 09:26 Galderma to Acquire Award-winning ALASTIN Skincare® Enhancing Its Integrated Dermatology Platform to Continue Delivering the Best Experience to Patients
2021-11-26 14:22 Vifor Pharma supports Iron Deficiency Day 2021: Call to action for early iron deficiency diagnosis
2021-11-25 18:31 MTTI and Monrol Have Signed a Clinical Supply Agreement for Lu-177 n.c.a.
2021-11-24 15:35 Exscientia to Present at Evercore ISI 4th Annual HealthCONx Virtual Conference
2021-11-24 09:47 Takeda’s LIVTENCITYTM (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV), Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies
2021-11-22 16:22 Merck Highlights Novel Mechanisms with the Potential to Transform Standards of Care in Several Cancers, MS, and Lupus
2021-11-22 14:35 Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG
2021-11-19 14:56 Exscientia Business Update for Third Quarter 2021
2021-11-19 10:44 Bluehole Publishes a Feature Story on Global Advocacy for Tobacco Harm Reduction Prior to WHO FCTC COP9
2021-11-19 09:28 Braun Announces Winners of 21st Edition of the BraunPrize International Design Competition, Celebrating Good Design for a Better Future
2021-11-18 22:09 BESREMi® (Ropeginterferon alfa-2b) approved by the US FDA
2021-11-18 14:11 Court Orders Search and Seizure of Products From Suspected Infringers of Seoul Viosys’ Patents in Europe

Business Wire Weibo

Press Releases

Latest Releases